Novartis predicts rising sales and minimal disruption from coronavirus
Share:
BASEL, Switzerland (Reuters) - Novartis boss Vas Narasimhan expects higher sales and profitability this year, lifted by its broad range of drugs, and minimal disruption to its supply chain from the coronavirus outbreak in China.The Swiss drugmaker's upbeat outlook and quarterly results on Wednesday outshone the previous day's results from Pfizer and set the bar for rival Roche , which is expected to report higher 2019 sales and profit on Thursday. Novartis shares were up 1.5% at 1337 GMT after..